FierceBiotech22h
Entrada's 2-year ordeal ends as FDA lifts hold on DMD drug
Entrada Therapeutics is finally able to get its Duchenne muscular dystrophy candidate (DMD) back on track after the FDA ...
ENDPOINTS NEWS22h
FDA lifts hold on En­trada's Duchenne drug af­ter two years
Phase 1b US study planned for 2026, as company competes with NS Pharma and Avidity Biosciences in exon 44 space ...
www.cs.cmu.edu18h
Introduction to Machine Learning
10-301 and 10-601 are identical. Undergraduates must register for 10-301 and graduate students must register for 10-601. Students entering the class are expected to have a pre-existing working ...